Relationship between volume, dose and local control in stereotactic radiosurgery of brain metastasis

References

• Smith M L, Lee J Y. Stereotactic radiosurgery in the management of brain metastasis. Neurosurg Focus 2007; 22(E3)1–8
   Google Scholar
• Pollock B E, Brown P D, Foote R L, Stafford S L, Schomberg P J. Properly selected patients with multiple brain metastases may benefit from aggressive treatment of their intracranial disease. J Neurooncol 2003; 61: 73–80
   PubMed Web of Science ®Google Scholar
• Kanner A A, Suh J H, Siomin V E, Lee S Y, Barnett G H. Vogelbaum MA. Posterior fossa metastases: aggressive treatment improves survival. Stereotact Funct Neurosurg 2003; 81: 18–23
   PubMed Web of Science ®Google Scholar
• Kaal E C, Niel C G, Vecht C J. Therapeutic management of brain metastasis. Lancet Neurol 2005; 5: 289–298
   Web of Science ®Google Scholar
• Patchell R A, Tibbs P A, Walsh J W, et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990; 322: 494–500
   PubMed Web of Science ®Google Scholar
• Vecht C J, Haaxma-Reiche H, Noordijk E M, et al. Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery?. Ann Neurol 1993; 33: 583–590
   PubMed Web of Science ®Google Scholar
• Gaspar L, Scott C, Rotman M, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997; 37: 745–751
   PubMed Web of Science ®Google Scholar
• Macdonald D R, Cascino T L, Schold S C, Jr, Cairncross J G. Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 1990; Jul;8(7)1277–1280
   PubMed Web of Science ®Google Scholar
• Joseph J, Adler J R, Cox R S, Hancock S L. Linear accelerator-based stereotaxic radiosurgery for brain metastases:the influence of number of lesions on survival. J Clin Oncol 1996; 14: 1085–1092
   PubMed Web of Science ®Google Scholar
• Chidel M A, Suh J H, Reddy C A, Chao S T, Lundbeck M F, Barnett G H. Application of recursive partitioning analysis and evaluation of the use of whole brain radiation among patients treated with stereotactic radiosurgery for newly diagnosed brain metastases. Int J Radiat Oncol Biol Phys 2000; 47: 993–999
   PubMed Web of Science ®Google Scholar
• Becker G, Jeremic B, Engel C, et al. Radiosurgery for brain metastases: the Tuebingen experience. Radiother Oncol 2002; 62: 233–237
   PubMed Web of Science ®Google Scholar
• Andrews D W, Scott C B, Sperduto P W, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 2004; 363: 1665–1672
   PubMed Web of Science ®Google Scholar
• McDermott M W, Sneed P K. Radiosurgery in metastatic brain cancer. Neurosurgery 2005; 57(Suppl)45–53
   Google Scholar
• Borgelt B, Gelber R, Kramer S, et al. The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1980; 6: 1–9
   PubMed Web of Science ®Google Scholar
• Maor M H, Frias A E, Oswald M J. Palliative radiotherapy for brain metastases in renal carcinoma. Cancer 1988; 62: 1912–1917
   PubMed Web of Science ®Google Scholar
• Mahmoud-Ahmed A S, Suh J H, Lee S Y, Crownover R L, Barnett G H. Results of whole brain radiotherapy in patients with brain metastases from breast cancer: a retrospective study. Int J Radiat Oncol Biol Phys 2002; 54: 810–817
   PubMed Web of Science ®Google Scholar
• Fleckenstein K, Hof H, Lohr F, Wenz F, Wannenmacher M. Prognostic factors for brain metastases after whole brain radiotherapy. Data from a single institution. Strahlenther Onkol 2004; 180: 268–273
   PubMed Web of Science ®Google Scholar
• Alexander E, Moriarty T M, Davis R B, et al. Stereotactic radiosurgery for the definitive, noninvasive treatment of brain metastases. J Natl Cancer Inst 1995; 87: 34–40
   PubMed Web of Science ®Google Scholar
• Sperduto P W, Berkey B, Gaspar L E, Mehta M, Curran W. A new prognostic index and comparison to three other indices for patients with brain metastases: An analysis of 1,960 patients in the RTOG database. Int J Radiat Oncol Biol Phys 2008; 70: 510–514
   PubMed Web of Science ®Google Scholar
• Shirato H, Takamura A, Tomita M, et al. Stereotactic irradiation without whole-brain irradiation for single brain metastasis. Int J Radiat Oncol Biol Phys 1997; 37: 385–391
   PubMed Web of Science ®Google Scholar
• Pirzkall A, Debus J, Lohr F, et al. Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases. J Clin Oncol 1998; 16: 3563–3569
   PubMed Web of Science ®Google Scholar
• Sneed P K, Lamborn K R, Forstner J M, et al. Radiosurgery for brain metastases: is whole brain radiotherapy necessary?. Int J Radiat Oncol Biol Phys 1999; 43: 549–558
   PubMed Web of Science ®Google Scholar
• Varlotto J M, Flickinger J C, Niranjan A, Bhatnagar A, Kondziolka D, Lunsford L D. The impact of whole-brain radiation therapy on the long-term control and morbidity of patients surviving more than one year after gamma knife radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 2005; 62: 1125–1132
   PubMed Web of Science ®Google Scholar
• Aoyama H, Shirato H, Tago M, et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 2006; 295: 2483–2491
   PubMed Web of Science ®Google Scholar
• DeAngelis L M, Delattre J Y, Posner J B. Radiation-induced dementia in patients cured of brain metastases. Neurology 1989; 39: 789–796
   PubMed Web of Science ®Google Scholar
• Swennen M H, Bromberg J E, Witkamp T D, Terhaard C H, Postma T J, Taphoorn M J. Delayed radiation toxicity after focal or whole brain radiotherapy for low-grade glioma. J Neurooncol 2004; 66: 333–339
   PubMed Web of Science ®Google Scholar
• Loeffler J S, Kooy H M, Wen P Y, et al. The treatment of recurrent brain metastases with stereotactic radiosurgery. J Clin Oncol 1990; 8: 576–582
   PubMed Web of Science ®Google Scholar
• Noel G, Proudhom M A, Valery C A, et al. Radiosurgery for re-irradiation of brain metastasis: results in 54 patients. Radiother Oncol 2001; 60: 61–67
   PubMed Web of Science ®Google Scholar
• Sheehan J, Kondziolka D, Flickinger J, Lunsford L D. Radiosurgery for patients with recurrent small cell lung carcinoma metastatic to the brain: outcomes and prognostic factors. J Neurosurg 2005; 102(Suppl)247–254
   PubMed Web of Science ®Google Scholar
• Kwon K Y, Kong D S, Lee J I, Nam D H, Park K, Kim J H. Outcome of repeated radiosurgery for recurrent metastatic brain tumors. Clin Neurol Neurosurg 2007; 109: 132–137
   PubMed Web of Science ®Google Scholar
• Matsuo T, Shibata S, Yasunaga A, et al. Dose optimization and indication of Linac radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 1999; 45: 931–939
   PubMed Web of Science ®Google Scholar
• Nieder C, Nestle U, Walter K, Niewald M, Schnabel K. Dose-response relationships for radiotherapy of brain metastases: role of intermediate-dose stereotactic plus whole-brain radiotherapy. Am J Clin Oncol 2000; 23: 584–588
   PubMed Web of Science ®Google Scholar
• Shiau C Y, Sneed P K, Shu H K, et al. Radiosurgery for brain metastases: relationship of dose and pattern of enhancement to local control. Int J Radiat Oncol Biol Phys 1997; 37: 375–383
   PubMed Web of Science ®Google Scholar
• Jawahar A, Shaya M, Campbell P, et al. Role of stereotactic radiosurgery as a primary treatment option in the management of newly diagnosed multiple (3–6) intracranial metastases. Surg Neurol 2005; Sep;64: 207–212
   PubMedGoogle Scholar
• Shaw E, Scott C, Souhami L, et al. Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys 2000; 47: 291–298
   PubMed Web of Science ®Google Scholar
• Vogelbaum M A, Angelov L, Lee S Y, Li L, Barnett G H, Suh J H. Local control of brain metastases by stereotactic radiosurgery in relation to dose to the tumor margin. J Neurosurg 2006; 104: 907–912
   PubMed Web of Science ®Google Scholar
• Tokuuye K, Akine Y, Sumi M, et al. Reirradiation of brain and skull base tumors with fractionated stereotactic radiotherapy. Int J Radiat Oncol Biol Phys 1998; 40: 1151–1155
   PubMed Web of Science ®Google Scholar
• Manning M A, Cardinale R M, Benedict S H, et al. Hypofractionated stereotactic radiotherapy as an alternative to radiosurgery for the treatment of patients with brain metastases. Int J Radiat Oncol Biol Phys 2000; 47: 603–608
   PubMed Web of Science ®Google Scholar
• Lindvall P, Bergstrom P, Lofroth P O, Henriksson R, Bergenheim A T. Hypofractionated conformal stereotactic radiotherapy alone or in combination with whole-brain radiotherapy in patients with cerebral metastases. Int J Radiat Oncol Biol Phys 2005; 61: 1460–1466
   PubMed Web of Science ®Google Scholar
• Ernst-Stecken A, Ganslandt O, Lambrecht U, Sauer R, Grabenbauer G. Phase II trial of hypofractionated stereotactic radiotherapy for brain metastases: results and toxicity. Radiother Oncol 2006; 81: 18–24
   PubMed Web of Science ®Google Scholar
• Narayana A, Chang J, Yenice K, et al. Hypofractionated stereotactic radiotherapy using intensity-modulated radiotherapy in patients with one or two brain metastases. Stereotact Funct Neurosurg 2007; 85: 82–87
   PubMed Web of Science ®Google Scholar
• Davey P, Schwartz M L, Scora D, Gardner S, O'Brien P F. Fractionated (split dose) radiosurgery in patients with recurrent brain metastasis: implications for survival. Br J Neurosurg 2007; 21: 491–495
   PubMed Web of Science ®Google Scholar
• Flickinger J C, Kondziolka D, Lunsford L D, et al. A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis. Int J Radiat Oncol Biol Phys 1994; 28: 797–802
   PubMed Web of Science ®Google Scholar
• Kim Y S, Kondziolka D, Flickinger J C, Lunsford L D. Stereotactic radiosurgery for patients with nonsmall cell lung carcinoma metastatic to the brain. Cancer 1997; 80: 2075–2083
   PubMed Web of Science ®Google Scholar
• Linzer D, Ling S M, Villalobos H, et al. Gamma knife radiosurgery for large volume brain tumors: an analysis of acute and chronic toxicity. Stereotact Funct Neurosurg 1998; 70(Suppl)11–18
   PubMed Web of Science ®Google Scholar
• Chin L S, Ma L, DiBiase S. Radiation necrosis following gamma knife surgery: a case-controlled comparison of treatment parameters and long-term clinical follow up. J Neurosurg 2001; 94: 899–904
   PubMed Web of Science ®Google Scholar
• Valery C A, Cornu P, Noel G, et al. Predictive factors of radiation necrosis after radiosurgery for cerebral metastases. Stereotact Funct Neurosurg 2003; 81: 115–119
   PubMed Web of Science ®Google Scholar
• Leber K A, Eder H G, Kovac H. Anegg U, Pendl G. Treatment of cerebral radionecrosis by hyperbaric oxygen therapy. Stereotact Funct Neurosurg 1998; 70(Suppl)229–236
   PubMed Web of Science ®Google Scholar
• Ohguri T, Imada H, Kohshi K, et al. Effect of prophylactic hyperbaric oxygen treatment for radiation-induced brain injury after stereotactic radiosurgery of brain metastases. Int J Radiat Oncol Biol Phys 2007; 67: 248–255
   PubMed Web of Science ®Google Scholar
• Jagannathan J, Petit J H, Balsara K, Hudes R, Chin L S. Long-term survival after gamma knife radiosurgery for primary and metastatic brain tumors. Am J Clin Oncol 2004; 27: 441–444
   PubMed Web of Science ®Google Scholar